Mechanisms of cisplatin ototoxicity: Theoretical review

Journal of Laryngology and Otology

Volumn 127, Issue 6, 2013, Pages 536-541

  Goncalves M S ^a   Silveira, A F ^a   Teixeira, A R ^b   Hyppolito, M A ^c  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cisplatin; Cochlea; Free Radicals; Hearing Loss; Toxicity

Indexed keywords

4 HYDROXYNONENAL; ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMIFOSTINE; CASPASE; CELL DNA; CISPLATIN; FOSFOMYCIN; GINKGO BILOBA EXTRACT; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; SODIUM THIOSULFATE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

APOPTOSIS; CELL MEMBRANE; COCHLEA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; HUMAN; LIPID PEROXIDATION; NONHUMAN; OTOTOXICITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SINGLE DRUG DOSE; SYSTEMATIC REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; COCHLEA; COCHLEAR DISEASES; HUMANS; REACTIVE OXYGEN SPECIES;

EID: 84878790018     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215113000947     Document Type: Review

References (69)

1. Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005;4:307-20
2. Jordan JA, Schwade ND, Truelson JM. Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum. Laryngoscope 1999;109:1259-62
3. Hyppolito MA, Oliveira JA. Ototoxicity, otoprotection and self defense of the cochlear outer hair cells [in Brazilian Portuguese]. Medicina (Ribeirão Preto) 2005;38:279-89
4. Saleh S, El-Demerdash E. Protective effects of L-Arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin Pharmacol Toxicol 2005;97:91-7
5. Bates DE, Beaumont SJ, Baylis BW. Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother 2002;36: 446-51
6. Ilha L, Kasse C, Mesquita Neto O, Almeida CR, Cruz OLM. Cisplatin-induced ototoxicity in guinea pigs: dose-related effects - a functional evaluation [in Brazilian Portuguese]. ACTA ORL/Técnicas em Otorrinolaringologia 2007;25: 112-18
7. Rybak LP, Mukherjea D, Jajoo S, Ramkumar V. Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 2009;219:177-86
8. Rybak LP, Kelly T. Ototoxicity: bioprotective mechanisms. Curr Opin Otolaryngol Head Neck Surg 2003;11:328-33
9. Schweitzer VG. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope 1993;103:1-52
10. Hinojosa R, Riggs LC, Strauss M, Matz GJ. Temporal bone histopathology of cisplatin ototoxicity. Am J Otol 1995;16:731-41
11. Lee JE, Nakagawa T, Kita T, Kim TS, Iguchi F, Endo T et al. Mechanisms of apoptosis induced by cisplatin in marginal cells in mouse stria vascularis. ORL J Otorhinolaryngol Relat Spec 2004;66:111-18
12. Comis SD, Rhys-Evans PH, Osborne MP, Pickles JO, Jeffries DJR, Pearse HAC. Early morphological and chemical changes induced by cisplatin in the guinea pig organ of Corti. J Laryngol Otol 1986;100:1375-83
13. Estrem SA, Babin RW, Ryu JH, Moore KC. Cis- Diamminedichloroplatinum (II) ototoxicity in the guinea pig. Otolaryngol Head Neck Surg 1981;89:638-45
14. Feghali JG, Lefebvre PP, Staecker H, Kopke R, Frenz DA, Malgrange B et al. Mammalian auditory hair cell regeneration/ repair and protection: a review and future directions. Ear Nose Throat J 1998;77:276-85
15. Simon T, Hero B, DupuisW, Selle B, Berthold F. The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Pediatr 2002;214:149-52
16. Casares C, Ramírez-Camacho R, Trinidad A, Roldán A, Jorge E, García-Berrocal Jr. Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models. Eur Arch Otorhinolaryngol 2012;269: 2455-9
17. Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G. Evoked otoacoustic emissions - an approach for monitoring cisplatin induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 2001;59:47-57
18. Garcia AP, Iório MCM, Petrilli AS. Audiological monitoring of cisplatin exposed patients [in Brazilian Portuguese]. Rev Bras Otorrinolaringol 2003;69:215-21
19. Li Y, Womer RB, Silber JH. Predicting cisplatin ototoxicity in children: influence of age and the cumulative dose. Eur J Cancer 2004;40:2445-51
20. Schneider CD, Oliveira AR. Oxygen free radicals and exercise: mechanisms of synthesis and adaptation to physical training [in Brazilian Portuguese]. Rev Bras Med Esporte 2004;10:308-13
21. Ferreira ALA, Matsubara LS. Free radicals: concepts, diseases, defense system and oxidative stress [in Brazilian Portuguese]. Rev Assoc Med Bras 1997;43:61-8
22. Barreiros ALBS, David JM, David JP. Oxidative stress: relations between the formation of reactive species and the organism's defense [in Brazilian Portuguese]. Quim Nova 2006;29:113-23
23. Freeman BA, Crapo JD. Biology of disease: free radical and tissue injury. Lab Invest 1982;47:412-26
24. Kumar V, Abbas AK, Fausto N. Cellular injury, cell adaptation and cell death. In: Robbins and Cotran: Pathologic Basis of Disease, 7th edn. Philadelphia: Elsevier, 2005;11-48
25. Ross D, Moldeus P. Antioxidant defense systems and oxidative stress. In: Vigo-Pelfrey C. Membrane Lipid Oxidation. Boca Raton: CRC Press, 1991;151-70
26. Gutteridge JMC, Halliwell B. Antioxidants: molecules, medicines and myths. Biochem Biophys Res Commun 2010;393: 561-4
27. Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol 2000;21:513-20
28. Campbell KCM, Kalkanis J, Glatz FR. Ototoxicity: mechanisms, protective agents and monitoring. Curr Opin Otol Head Neck Sur 2000;8:436-40
29. Van Rujven MWM, De Groot JCMJ, Hendriksen F, Smoorenburg GF. Immunohistochemical detection of platinatedDNA in the cochlea of cisplatin-treated guinea pigs. Hear Res 2005;203:112-21
30. Mukherjea D, Jajoo S, Whitworth CA, Bunch JR, Turner JG, Rybak LP et al. Short interfering RNA against transient receptor potential vanilloid-1 attenuates cisplatin-induced hearing loss in the rat. J Neurosci 2008;28:13056-65
31. Bánfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, Krause K-H. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 2004;279:46065-72
32. Rybak LP. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg 2007;15: 364-9
33. Ikeda K, Sunose H, Takasaka T. Effects of free radicals on the intracellular calcium concentration in the isolated hair cell of the guinea pig cochlea. Acta Otolaryngol 1993;113:137-41
34. Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M et al. Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990;50:283-97
35. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-Activated ion channel in the pain pathway. Nature 1997;389:816-24
36. Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, Travers JB. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003;304:217-22
37. Zheng J, Dai C, Steyger PS, Kim Y, Vass Z, Ren T et al. Vanilloid receptors in hearing: altered cochlear sensitivity by vanilloids and expression of TRPV1 in the organ of corti. J Neurophysiol 2003;90:444-55
38. Devarajan P, Savoca M, Castaneda MP, Park MS, Esteban- Cruciani N, Kalinec G et al. Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways. Hear Res 2002;174:45-54
39. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995;76:386-94
40. Strayer DS, Rubin E. Cell injury. In: Rubin E, Gorstein F, Rubin R, Schwarting R, Strayer D. Rubin's Pathology: Clinicopathologic Foundations of Medicine, 4th edn [in Brazilian Portuguese]. São Paulo: Guanabara-Koogan, 2006; 2-39
41. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407:770-6
42. Huang T, Cheng AG, Stupak H, LiuW, Kim A, Staecker H et al. Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci 2000;18:259-70
43. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell death. Science 1998;281:1322-6
44. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000;69:217-45
45. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003;15:725-31
46. Sharifia AM, Eslami H, Larijani B, Davoodi J. Involvement of caspase-8, 9, and 3 in high glucose-induced apoptosis in PC12 cells. Neurosci Lett 2009;459:47-51
47. Grivicich I, Regner A, Rocha AB. Apoptosis: programmed cell death [in Brazilian Portuguese]. Rev Bras Cancerol 2007;53: 335-43
48. Harris MH, Thompson CB. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ 2000;7:1182-91
49. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 2003;39:615-47
50. Golstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nature Cell Biol 2000;2: 156-62
51. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-16
52. Amarante-Mendes GP, Green DR. The regulation of apoptotic cell death. Braz J Med Biol Res 1999;32:1053-61
53. Paronlin MB, Reason IJ. Apoptosis as a mechanism of tissue injury in hepatobiliary diseases [in Brazilian Portuguese]. Arq Gastroenterol São Paulo 2001;38:38-44
54. Alam SA, Ikeda K, Oshima T, Suzuki M, Kawase T, Kikuchi T et al. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res 2000;141:28-38
55. LiuW, Staecker H, Stupak H, Malgrange B, Lefebvre P, Van De Water TR. Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport 1998;9:2609-14
56. Cheng PW, Liu SH, Hsu CJ, Lin-Shiau SY. Correlation of increased activities of Na +, K+ -ATP-Ase and Ca2+ -ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs. Hear Res 2005;205:102-9
57. Cardinaal RM, de Groot JC, Huizing EH, Veldman JE, Smoorenburg GF. Histological effects of co-Administration of an ACTH(4-9) analog ORG 2766 on cisplatin ototoxicity in the albino guinea pig. Hear Res 2000;144:157-67
58. Kasse CA, Hyppolito MA, Cruz OLM, Oliveira JAA. Ototoxicity and otoprotection [in Brazilian Portuguese]. Rev Bras Med Otorrinolaringol 2008;4:105-15
59. Rybak L, Whitworth C, Somani S. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 1999;109:1740-4
60. Freitas MR, Figueiredo AA, Brito GAC, Leitão RFC, Carvalho JV Jr, Gomes RM Jr et al. The role of apoptosis in cisplatininduced ototoxicity in rats [in Brazilian Portuguese]. Braz J Otorhinolaryngol 2009;75:745-52
61. Sha SH, Taylor R, Forge A, Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 2001;155:1-8
62. Usami S, Hjelle OP, Ottersen OP. Differential cellular distribution of glutathione - an endogenous antioxidant - in the guinea pig inner ear. Brain Res 1996;743:337-40
63. Muldoon LL, Pagel MA, Kroll RA, Brummett RE, Doolittle ND, Zuhowski EG et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 2000;6:309-15
64. Hyppolito MA, Oliveira JAA, Lessa RM, Rossato M. Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy [in Brazilian Portuguese]. Rev Bras Otorrinolaringol 2005;71:168-273
65. Hyppolito MA, Oliveira JAA, Rossato M, Holanda F. Cisplatin ototoxicity and otoprotector to ciliated cells by ginkgo biloba extract: anatomic and electrophysiologic study [in Brazilian Portuguese]. Rev Bras Otorrinolaringol 2003;69:504-11
66. Kalkanis JG, Whitworth C, Rybak LP. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 2004;114:538-42
67. Feghali JG, Liu W, Van De Water TR. L-N-Acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001;111:1147-55
68. Fetoni AR, Ralli M, Sergi B, Parrilla C, Troiani D, Paludetti G. Protective effects of N-Acetylcysteine on noise-induced hearing loss in guinea pigs. Acta Otorhinolaryngol Ital 2009;29:70-5
69. Riga MG, Chelis L, Kakolyris S, Papadopoulos S, Stathakidou S, Chamalidou E et al. Transtympanic injections of N-Acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy. Am J Clin Oncol 2013;36: 1-6